InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Stenhouse Mark. Insider active across 2 companies, notably Prometheus Biosciences, Inc.. Aggregated, 6 disclosures have been recorded. Activity tracked since 9 December 2022. The latest transaction was filed on 3 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Stenhouse Mark is a declarant linked to Phathom Pharmaceuticals, Inc., where he is Director, and to Prometheus Biosciences, Inc., where he is Chief Operating Officer. His record includes 6 filings, and across the recent filings we hold, the period runs from 2022-12-13 to 2025-06-05, with the modal transaction nature shown as Attribution.